Table 2 Microbiological characteristics of FN cases
Variables | ASP group | Non-ASP group |
|---|---|---|
N = 162 | N = 145 | |
Documented BSI (%) | 57 (35.2) | 58 (40.0) |
Blood isolates | ||
- Escherichia coli (%) | 20 (12.3) | 24 (16.5) |
- Coagulase-negative staphylococci (%) | 16 (9.9) | 20 (13.7) |
- Klebsiella pneumonia (%) | 6 (3.7) | 7 (4.8) |
- Pseudomonas aeruginosa (%) | 6 (3.7) | 5 (3.4) |
- Viridans strepcococci (%) | 6 (3.7) | 2 (1.3) |
- Enterococcus spp. (%) | 2 (1.2) | 2 (1.3) |
- Serratia spp. (%) | 1 (0.6) | 1 (0.7) |
- Enterobacter spp. (%) | 2 (1.2) | 0 (0) |
- Candida spp. (%) | 0 (0) | 2 (1.3) |
- Salmonella spp. (%) | 1 (0.6) | 0 (0) |
- Staphylococcus aureus (%) | 0 (0) | 1 (0.7) |
- Kocuria varians (%) | 1 (0.6) | 0 (0) |
BSI involving Gram-positive MDR bacteria | 12 (7.4) | 15 (10.3) |
BSI involving Gram-negative MDR bacteria | 9 (5.5) | 3 (2.0) |